ClearPoint Neuro
NASDAQ: CLPT
Healthcare
Medical Devices
Rank
#15333
Market Cap
366.81 M
Volume
293,106
Price
13.11
Change (%)
5.55%
Country or region
United States
United States
ClearPoint Neuro's latest marketcap:
366.81 M
As of May 7, 2025, ClearPoint Neuro's market capitalization has reached $366.81 M. According to our data, ClearPoint Neuro is the 15333th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 366.81 M |
| Revenue (ttm) | 31.39 M |
| Net Income (ttm) | -18,914,000 |
| Shares Out | 27.98 M |
| EPS (ttm) | -0.70 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 13, 2025 |
Market Cap Chart
Data Updated: May 7, 2025
ClearPoint Neuro's yearly market capitalization.
ClearPoint Neuro has seen its market value grow from $76.80 M to $366.81 M since 2012, representing a total increase of 377.62% and an annual compound growth rate (CAGR) of 13.50%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 7, 2025 | $366.81 M | -9.4% |
| December 31, 2024 | $424.30 M | 153.77% |
| December 29, 2023 | $167.20 M | -19.62% |
| December 30, 2022 | $208 M | -21.57% |
| December 31, 2021 | $265.20 M | -1.08% |
| December 31, 2020 | $268.10 M | 267.26% |
| December 31, 2019 | $73 M | 337.13% |
| December 31, 2018 | $16.70 M | -41.61% |
| December 29, 2017 | $28.60 M | 132.52% |
| December 30, 2016 | $12.30 M | -56.84% |
| December 31, 2015 | $28.50 M | -41.84% |
| December 31, 2014 | $49 M | -42.22% |
| December 31, 2013 | $84.80 M | 10.42% |
| December 31, 2012 | $76.80 M |
Company Profile
Frequently Asked Questions
As of May 7, 2025, ClearPoint Neuro (including the parent company, if applicable) has an estimated market capitalization of $366.81 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
ClearPoint Neuro global market capitalization ranking is approximately 15333 as of May 7, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 1998 |
| IPO Date | n/a |
| Employees | 115 |
| CEO | |
| Sector | Healthcare |
| Industry | Medical Devices |
| Address |
